{ "ok": true, "cik": "1802255", "ticker": "GRDN", "name": "Guardian Pharmacy Services, Inc.", "filings": [ { "form": "8-K", "filed": "2026-09-10", "items": [ "8.01 Other Events" ], "url": "https://www.sec.gov/Archives/edgar/data/1802255/000119312526387858/0001193125-26-387858-index.htm" }, { "form": "10-Q", "filed": "2026-08-06", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1802255/000119312526338074/0001193125-26-338074-index.htm" }, { "form": "8-K", "filed": "2026-08-06", "items": [ "2.02 Results of Operations and Financial Condition", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1802255/000119312526338032/0001193125-26-338032-index.htm" }, { "form": "8-K", "filed": "2026-06-22", "items": [ "5.02 Departure or Election of Directors; Appointment of Officers", "7.01 Regulation FD Disclosure", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1802255/000119312526277596/0001193125-26-277596-index.htm" }, { "form": "8-K", "filed": "2026-05-28", "items": [ "1.01 Entry into a Material Definitive Agreement", "2.03 Creation of a Direct Financial Obligation", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1802255/000119312526245235/0001193125-26-245235-index.htm" }, { "form": "8-K", "filed": "2026-05-07", "items": [ "5.07 Submission of Matters to a Vote of Security Holders" ], "url": "https://www.sec.gov/Archives/edgar/data/1802255/000119312526211924/0001193125-26-211924-index.htm" } ], "events12m": 11, "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001802255.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1802255" }, "license": "Figures as filed with the SEC. Card text CC BY 4.0, POPS4.", "notAdvice": "Reporting, not investment advice. No price targets, no buy or sell views.", "edgar": "🫧 Edgar looked up Guardian Pharmacy Services, Inc. ($GRDN). Last filing: 8-K (8.01 Other Events), 2026-09-10. 11 event filings (8-K) in the past twelve months.", "auditor": { "changes": [], "nonReliance": [], "restatedSince": null }, "metrics": { "fiscalYearEnd": "2025-12-31", "revenue": 1448685000, "revenueGrowth1y": 0.1793181261290011, "revenueGrowthPerYear": null, "yearsOfData": 2, "operatingMargin": 0.050184132506376475, "operatingMarginPrior": -0.05122072534473453, "netMargin": 0.033974949695758566, "operatingCashFlow": 100255000, "capitalSpending": null, "freeCashFlow": null, "researchAndDevelopment": null, "researchShareOfRevenue": null, "cash": 65619000, "longTermDebt": 0, "longTermDebtChange": null, "revenueHistory": [ { "fiscalYearEnd": "2024-12-31", "revenue": 1228409000 }, { "fiscalYearEnd": "2025-12-31", "revenue": 1448685000 } ], "totalEquity": 217924000, "totalAssets": 412658000, "equityRatio": 0.52809832839785, "returnOnEquity": 0.22585396743818947, "dividendsPaid": null, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "priceBased": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown.", "range80": { "low": 1358738619.387063, "high": 2013762367.2469902, "baseline": 1708460479.551192, "n": 4599, "band": "b1" }, "ifPaceHeld": { "low": 1358738619.387063, "high": 2013762367.2469902 } }, "edgarette": "🔖 Exposure: revenue $1.4B (FY2025), total debt $0K. Experience: revenue up 17.9% on the year; operating margin 5.0%, up from -5.1%. Soundness: equity 52.8% of assets, return on equity 22.6%. Credibility: 2 audited years, moderate weight. Range: 80% of past cases like this landed between $1.4B and $2.0B next year (method v3, set from 4,599 SEC company-years; on a year the method never saw, 83% landed inside). A range, not a forecast. Against peers (57 filers, $50M+ revenue, its industry group): operating margin 5.0% against a 0.6% median; growth 17.9% against 4.1%.", "peers": { "sic": 5912, "sicDescription": "Retail-Drug Stores and Proprietary Stores", "calendarYear": 2025, "minRevenue": 50000000, "depth": 2, "group": "59", "growth": [ 0.0413, 57 ], "opMargin": [ 0.0057, 57 ], "equityRatio": [ 0.2951, 52 ], "returnOnEquity": [ 0.0257, 40 ], "payoutRatio": [ 0.2479, 13 ] }, "summary": "Guardian Pharmacy Services (GRDN) grew revenue 17.9% in FY2025 to $1.4 billion, operating margin 5.0% against a 0.6% median for retail-drug stores and proprietary stores, equity 52.8% of assets. Every figure is from the company’s own annual report filed with the SEC.", "chart": "
Guardian Pharmacy Services, Inc. against its own record and its peers
Operating marginPeer median 0.6%5.0%Revenue, on the yearPeer median 4.1%17.9%Equity of assetsPeer median 29.5%52.8%Return on equityPeer median 2.6%22.6%Gold tick: the median of 40–52 peers with $50M+ revenue in retail-drug stores and proprietary stores
", "chartHorizon": null, "backtest": { "tests": 0, "hits": 0, "rate": null, "method": "v3", "note": "hindsight: past years, same calibrated range. The range was calibrated on 2022-2024 SEC data, so years in that window are partly in-sample." }, "registry": { "logged": "2026-09-20T15:18:51.611Z", "hash": "d1a57a8a1b74b96e", "status": "open" }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "schema": "pops4.edgarette.card/1", "card": { "summary": "Guardian Pharmacy Services (GRDN) grew revenue 17.9% in FY2025 to $1.4 billion, operating margin 5.0% against a 0.6% median for retail-drug stores and proprietary stores, equity 52.8% of assets. Every figure is from the company’s own annual report filed with the SEC.", "exposure": { "fiscalYearEnd": "2025-12-31", "revenue": 1448685000, "totalDebt": 0, "cash": 65619000 }, "experience": { "revenueGrowth1y": 0.1793181261290011, "revenueGrowthPerYear": null, "operatingMargin": 0.050184132506376475, "operatingMarginPrior": -0.05122072534473453, "netMargin": 0.033974949695758566, "freeCashFlow": null }, "soundness": { "equityRatio": 0.52809832839785, "returnOnEquity": 0.22585396743818947, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "note": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown." }, "peers": { "sic": 5912, "sicDescription": "Retail-Drug Stores and Proprietary Stores", "calendarYear": 2025, "minRevenue": 50000000, "depth": 2, "group": "59", "growth": [ 0.0413, 57 ], "opMargin": [ 0.0057, 57 ], "equityRatio": [ 0.2951, 52 ], "returnOnEquity": [ 0.0257, 40 ], "payoutRatio": [ 0.2479, 13 ] }, "credibility": { "auditedYears": 2, "weight": "moderate", "standard": "ASOP No. 25", "nonReliance": null, "auditorChange": null }, "range": { "low": 1358738619.387063, "high": 2013762367.2469902, "baseline": 1708460479.551192, "coverage": 0.8, "method": "v3", "basis": "next fiscal year revenue: baseline = revenue x (1 + mean of one-year and three-year pace); range = 10th to 90th percentile of how SEC company-years of the same size band actually turned out", "calibratedOn": { "companyYears": 4599, "sizeBand": "b1" }, "kind": "a calibrated range, not a forecast; no view on the share price", "track": { "backtest": { "tests": 0, "hits": 0, "rate": null, "method": "v3", "note": "hindsight: past years, same calibrated range. The range was calibrated on 2022-2024 SEC data, so years in that window are partly in-sample." }, "registry": { "logged": "2026-09-20T15:18:51.611Z", "hash": "d1a57a8a1b74b96e", "status": "open" }, "scorecard": "https://www.pops4.com/boards/scorecard" } }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001802255.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1802255" } }, "definitions": { "operatingMargin": "Operating income divided by revenue.", "netMargin": "Net income divided by revenue.", "freeCashFlow": "Cash from operations minus spending on property and equipment.", "researchShareOfRevenue": "Research and development expense for the year as a share of revenue, both as filed.", "equityRatio": "Shareholders equity as a share of total assets, both as filed. Higher means less of the company is owed to someone else.", "returnOnEquity": "Net income for the year against shareholders equity at year end.", "payoutRatio": "Dividends paid as a share of net income, in the year the cash went out.", "dividendYearsRising": "Consecutive years, counted back from the last on record, in which dividend per share rose. A fall ends the run and is reported as dividendCut.", "revenueGrowthPerYear": "Compound annual growth between the first and latest fiscal years shown.", "credibility": "How much weight a record deserves, in the actuarial sense (ASOP No. 25): more audited years, more weight.", "peers": "Medians of SEC filers with $50M+ revenue in the same industry code (SIC), narrowest group with at least 8 filers, calendar-year figures from SEC XBRL frames.", "backtest": "The same if-the-pace-held arithmetic applied to the company's own past years, scored against what it actually reported next. Hindsight, and labelled so." } }